Real-time enrollment status for this multiple myeloma (mm) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:35 PM UTC
| NCT Number | NCT07637578 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma (MM) |
| Phase | PHASE2 |
| Target Enrollment | 46 participants |
| Active Locations | 5 sites in the US |
| Sponsor | SCRI Development Innovations, LLC |
| Last Updated on CT.gov | August 11, 2026 (2 weeks ago) |
As of August 27, 2026: Clinical trial NCT07637578 is currently recruiting participants. This phase2 study for multiple myeloma (mm) is actively seeking new participants at 5 locations across the United States. The study is sponsored by SCRI Development Innovations, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07637578 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07637578 was last updated 2 weeks ago (August 11, 2026). HelloStudys verifies this status automatically.